Skip to Content


In the US, actHIB (haemophilus b conjugate (prp-t) vaccine systemic) is a member of the drug class bacterial vaccines and is used to treat Haemophilus influenzae Prophylaxis.

US matches:

Ingredient matches for actHIB

Haemophilus Type b Conjugate Vaccine

Haemophilus Type b Conjugate Vaccine with conjugated tetanus toxoid (a derivative of Haemophilus Type b Conjugate Vaccine) is reported as an ingredient of actHIB in the following countries:

  • South Korea
  • United States

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.